A. Denjean

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

Olivier Sitbon, F Brénot, A. Denjean et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 314 citations

Hypertension, Pulmonary Hypertension, Pharmacotherapy +18

Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine.

Jacques Cerrina, A. Denjean, G Alexandre et al. · PubMed · 1981 · 167 citations

Asthma, Molecular Pharmacology, Allergy +15

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension

Olivier Sitbon, F Brénot, A. Denjean et al. · Réanimation Urgences · 1996 · 109 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +11

Accumulation of Platelets and Eosinophils in Baboon Lung after Paf-acether Challenge: Inhibition by Ketotifen

B. Arnoux, A. Denjean, Clive Page et al. · American Review of Respiratory Disease · 1988 · 94 citations

Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study

A. Denjean, J. Paris-Llado, V. Zupan et al. · European Journal of Pediatrics · 1998 · 80 citations · Full text

Asthma, Randomised Double-blind Study, Broncho-pulmonary Dysplasia +7